日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort

欧洲硬皮病试验和研究队列中系统性硬化症原发性心脏受累和慢性心力衰竭的评估

Györfi, Andrea-Hermina; Filla, Tim; Polzin, Amin; Tascilar, Koray; Buch, Maya; Tröbs, Monique; Matei, Alexandru-Emil; Airo, Paolo; Balbir-Gurman, Alexandra; Kuwert, Frederic; Mihai, Carina; Kabala, Anna; Graßhoff, Hanna; Callaghan, Julia; Isomura, Yohei; Mansour, Jennifer; Spierings, Julia; Tennoe, Anders Heiervang; Selvi, Enrico; Riccieri, Valeria; Hoffmann-Vold, Anna-Maria; Bergmann, Christina; Schett, Georg; Hunzelmann, Nicolas; van Laar, Jacob M; Saketkoo, Lesley Ann; Kuwana, Masataka; Siegert, Elise; Riemekasten, Gabriela; Distler, Oliver; du Four, Tessa; Smith, Vanessa; Truchetet, Marie-Elise; Distler, Jörg H W

A composite biomarker score to predict modified Rodnan skin score in systemic sclerosis: insight from autologous stem cell transplantation international scleroderma trial.

预测系统性硬化症改良 Rodnan 皮肤评分的综合生物标志物评分:来自自体干细胞移植国际硬皮病试验的启示。

Rodolfi Stefano, Clark Kristina, Abdi Bahja Ahmed, Roblin Elen, Kanitkar Medha, Ong Voon H, Voskuyl Alexandre E, De Vries-Bouwstra Jeska K, van Laar Jacob M, Denton Christopher P, Spierings Julia

A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's

一项二期临床试验正在研究mPGES-1抑制剂vipoglanstat治疗系统性硬化症相关雷诺氏症的疗效和安全性。

Tornling, Göran; Edenius, Charlotte; Pauling, John D; Denton, Christopher P; Olsson, Anna; Kowalski, Jan; Murray, Andrea; Anderson, Marina; Bhat, Smita; Del Galdo, Francesco; Hall, Frances; Korkosz, Mariusz; Krasowska, Dorota; Olas, Jacek; Smith, Vanessa; van Laar, Jacob M; Vonk, Madelon C; Wojteczek, Anna; Herrick, Ariane L

Dermal cellular senescence and EndMT in patients with systemic sclerosis undergoing cyclophosphamide or aHSCT treatment.

接受环磷酰胺或aHSCT治疗的系统性硬化症患者的真皮细胞衰老和EndMT

Chiu Yu-Hsiang, van Dijk Marijke, Goldschmeding Roel, van Laar Jacob M, de Vries-Bouwstra Jeska K, Spierings Julia

Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet's disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol

一项多中心、为期 26 周、开放标签的 II 期临床试验,旨在评估 JAK 抑制剂 filgotinib 治疗白塞氏病、特发性炎症性肌病和 IgG4 相关疾病的疗效:DRIMID 研究方案

Geertsema-Hoeve, Bettina C; van Laar, Jan A M; Raaphorst, Joost; Tas, Sander W; Welsing, Paco M J; Goekoop, Robbert J; Checa, Cesar Magro; Thurlings, Rogier M; Rekers, Nicolle H; Present, Erik; van Laar, Jacob M

HandScan criteria versus ACR/EULAR Boolean remission as treatment target in early rheumatoid arthritis: results of a randomized controlled trial

HandScan 标准与 ACR/EULAR 布尔缓解标准作为早期类风湿关节炎治疗目标的比较:一项随机对照试验的结果

van der Leeuw, Matthijs S; Welsing, Paco M J; Tekstra, Janneke; Westgeest, Antonius A A; Klaasen, Ruth; Gamala, Mihaela; Jacobs, Johannes W G; Verhoeven, Maxime M A; van Laar, Jacob M

Quantitative (18)F-FDG PET-CT can assess presence and extent of interstitial lung disease in early severe diffuse cutaneous systemic sclerosis

定量 (18)F-FDG PET-CT 可以评估早期重症弥漫性皮肤系统性硬化症中间质性肺疾病的存在和程度

Broens, Bo; Nossent, Esther J; Meijboom, Lilian J; Zwezerijnen, Gerben J C; Spierings, Julia; de Vries-Bouwstra, Jeska K; van Laar, Jacob M; van der Laken, Conny J; Voskuyl, Alexandre E

Association of autoantibodies with the IFN signature and NETosis in patients with systemic lupus erythematosus

系统性红斑狼疮患者自身抗体与IFN特征和NETosis的关联

Kaan, Ellen D; Brunekreef, Tammo E; Drylewicz, Julia; van den Hoogen, Lucas L; van der Linden, Maarten; Leavis, Helen L; van Laar, Jacob M; van der Vlist, Michiel; Otten, Henny G; Limper, Maarten

Design of TOLERANT: phase I/II safety assessment of intranodal administration of HSP70/mB29a self-peptide antigen-loaded autologous tolerogenic dendritic cells in patients with rheumatoid arthritis

TOLERANT 研究设计:I/II 期安全性评估,评估 HSP70/mB29a 自身肽抗原负载的自体耐受性树突状细胞在类风湿性关节炎患者中的结内给药疗效

Stoppelenburg, Arie Jan; Schreibelt, Gerty; Koeneman, Bouke; Welsing, Paco; Breman, Evert-Jan; Lammers, Laureen; de Goede, Anna; Duiveman-de Boer, Tjitske; van Eden, Willem; Leufkens, Paul; de Vries, I Jolanda M; Broere, Femke; van Laar, Jacob M

Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study

罕见复杂结缔组织疾病患者接种 COVID-19 疫苗的长期疗效:ERN-ReCONNET VACCINATE 研究

Tani, Chiara; Cardelli, Chiara; Depascale, Roberto; Gamba, Anna; Iaccarino, Luca; Doria, Andrea; Bandeira, Matilde; Dinis, Sara Paiva; Romão, Vasco C; Gotelli, Emanuele; Paolino, Sabrina; Cutolo, Maurizio; Di Giosaffatte, Niccolò; Ferraris, Alessandro; Grammatico, Paola; Cavagna, Lorenzo; Codullo, Veronica; Montecucco, Carlomaurizio; Longo, Valentina; Beretta, Lorenzo; Cavazzana, Ilaria; Fredi, Micaela; Peretti, Silvia; Guiducci, Serena; Matucci-Cerinic, Marco; Bombardieri, Stefano; Burmester, Gerd R; Fonseca, João E; Frank, Charissa; Galetti, Ilaria; Hachulla, Eric; Müller-Ladner, Ulf; Schneider, Matthias; Smith, Vanessa; Tamirou, Farah; Van Laar, Jacob M; Vieira, Ana; D'Urzo, Rossella; Cannizzo, Sara; Gaglioti, Andrea; Marinello, Diana; Talarico, Rosaria; Mosca, Marta